Abstract
Cyclooxygenase inhibitory and selectivity profile of a combined series of thirty one aryl sulphonamide compounds possessing 4-benzylideneamino or 4-phenyliminomethyl scaffolds were subjected to QSAR study using Hansch approach. The compounds in the selected series were characterized using classical aromatic substituent constants like hydrophobicity (p), molar refractivity (MR), Hammett electronic (s), electronic field effect (F), resonance effect (R), and some indicator variables encoding molecular group contributions. Statistically significant QSAR models were generated using multiple regression analysis and cross-validation tools. The derived QSAR models demonstrated that the COX-2 selectivity over COX-1 is predominantly influenced by the central core – N=C- of the diaryl system. Further, the study also indicated that the electronic properties and structural variation in the para position of the phenyl ring (B) governs the COX-2 selectivity of the title compounds. The derived results reveal the important structural features significant for improved COX-2 inhibitory activity and selectivity of these novel aryl sulfonamides.
Keywords: QSAR, COX-1, COX-2, Selectivity, NSAIDs, 4-benzylideneamino, 4-phenyliminomethyl, Aryl sulfonamide
Medicinal Chemistry
Title: QSAR Investigations on Benzylideneamino and Phenyliminomethyl Scaffolds for Selective COX-2 Inhibition: A Hansch Approach
Volume: 5 Issue: 5
Author(s): E. Manivannan and S. C. Chaturvedi
Affiliation:
Keywords: QSAR, COX-1, COX-2, Selectivity, NSAIDs, 4-benzylideneamino, 4-phenyliminomethyl, Aryl sulfonamide
Abstract: Cyclooxygenase inhibitory and selectivity profile of a combined series of thirty one aryl sulphonamide compounds possessing 4-benzylideneamino or 4-phenyliminomethyl scaffolds were subjected to QSAR study using Hansch approach. The compounds in the selected series were characterized using classical aromatic substituent constants like hydrophobicity (p), molar refractivity (MR), Hammett electronic (s), electronic field effect (F), resonance effect (R), and some indicator variables encoding molecular group contributions. Statistically significant QSAR models were generated using multiple regression analysis and cross-validation tools. The derived QSAR models demonstrated that the COX-2 selectivity over COX-1 is predominantly influenced by the central core – N=C- of the diaryl system. Further, the study also indicated that the electronic properties and structural variation in the para position of the phenyl ring (B) governs the COX-2 selectivity of the title compounds. The derived results reveal the important structural features significant for improved COX-2 inhibitory activity and selectivity of these novel aryl sulfonamides.
Export Options
About this article
Cite this article as:
Manivannan E. and Chaturvedi C. S., QSAR Investigations on Benzylideneamino and Phenyliminomethyl Scaffolds for Selective COX-2 Inhibition: A Hansch Approach, Medicinal Chemistry 2009; 5 (5) . https://dx.doi.org/10.2174/157340609789117877
DOI https://dx.doi.org/10.2174/157340609789117877 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Malaria-induced Alterations of Drug Kinetics and Metabolism in Rodents and Humans
Current Drug Metabolism Novel PET Tracers in the Management of Cardiac Sarcoidosis
Current Radiopharmaceuticals Lipoproteins in Atherosclerosis Process
Current Medicinal Chemistry Chemokines as Novel Therapeutic Targets in Autoimmune Thyroiditis
Recent Patents on DNA & Gene Sequences Patent Selections:
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Prospects of Embryonic Stem Cells in Treatment of Hematopoietic Disorders
Current Pharmaceutical Biotechnology Roles for Serotonin in Neurodevelopment: More than just Neural Transmission
Current Neuropharmacology Biologic and Novel Therapy of the Inflammatory Bowel Diseases
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents Activin Receptor-Like Kinase 1: a Novel Anti-angiogenesis Target from TGF-β Family
Mini-Reviews in Medicinal Chemistry Design, Synthesis and Potent Pharmaceutical Applications of Glycodendrimers:A Mini Review
Current Drug Discovery Technologies Oxaliplatin Regulates Chemotherapy Induced Peripheral Neuropathic Pain in the Dorsal Horn and Dorsal Root Ganglion via the Calcineurin/NFAT Pathway
Anti-Cancer Agents in Medicinal Chemistry Cancer Immunotherapy: The Role Regulatory T Cells Play and What Can be Done to Overcome their Inhibitory Effects
Current Molecular Medicine Siderophore-Antibiotic Conjugates Used as Trojan Horses Against Pseudomonas aeruginosa
Current Topics in Medicinal Chemistry Anti-Inflammatory Properties of Antipsychotics Via Microglia Modulations: Are Antipsychotics a ‘Fire Extinguisher’ in the Brain of Schizophrenia?
Mini-Reviews in Medicinal Chemistry Kynurenine Pathway and Disease: An Overview
CNS & Neurological Disorders - Drug Targets Alginate Based Nanocarriers for Drug Delivery Applications
Current Pharmaceutical Design Flavonoids and Related Compounds in Parasitic Disease Control
Mini-Reviews in Medicinal Chemistry A Retrospective Study on <i>Gloriosa superba</i> and Its Main Active Constituents
The Natural Products Journal Synthesis of Arylpiperazine Derivatives as Protease Activated Receptor 1 Antagonists and Their Evaluation as Antiproliferative Agents
Anti-Cancer Agents in Medicinal Chemistry Erratum
Mini-Reviews in Medicinal Chemistry